Aventis Pharma net profit rose 17.21 per cent year-on-year to Rs 49.7 crore for the quarter ended June 30, 2011.
The company had posted a net profit of Rs 42.4 crore during the quarter ended June 30, 2010, Aventis Pharma said in a filing to the Bombay Stock Exchange.
Net sales rose to Rs 302.8 crore during the quarter under review from Rs 271.5 crore in the corresponding period of the previous fiscal.
The company’s board has also declared an interim dividend of Rs 4 per equity share of Rs 10 face value.
Meanwhile, the company shares ended at Rs 2,077.50 on the BSE today, down 2.76 per cent from the previous close.